Sally E. Blount - 24 Apr 2026 Form 4 Insider Report for ABBOTT LABORATORIES (ABT)

Reporting relationship: Director
Issuer ticker: ABT
Reported as of: 24 Apr 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 28 Apr 2026, 18:17:13 UTC
Prior SEC filing: 02 May 2025
Source filing: View source filing
Reporting owner signature: /s/ Sally E. Blount by Jessica H. Paik, Attorney-in-Fact

Key filing fact

Sally E. Blount filed Form 4 for ABBOTT LABORATORIES (ABT) on 28 Apr 2026.

Key facts

This page summarizes Sally E. Blount's Form 4 filing for ABBOTT LABORATORIES (ABT).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 28 Apr 2026, 18:17.

Change

Previous filing in this sequence was filed on 02 May 2025.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001537286 Primary reporting owner

Blount Sally E.

Relationship: Director
Address: 100 ABBOTT PARK ROAD, ABBOTT PARK
Signature: /s/ Sally E. Blount by Jessica H. Paik, Attorney-in-Fact
Signature date: 28 Apr 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

ABT transaction

Common shares without par value

Award

Transaction value
Shares: +2,286
Change %: +6.7%
Price: $0.000000^*
Shares after: 36,344
Date: 24 Apr 2026
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Restricted stock unit award granted under the Abbott Laboratories 2017 Incentive Stock Program (the "Program"). The award will be paid, on a one-to-one basis, in Abbott common shares on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program).